In a report titled “Diagnostic Business Growth Catalysts Paired with Data Business Uncertainty; Initiate at Neutral,” Goldman Sachs analysts Evie Koslosky, Grey Smith and Miki Dejena argue that Tempus AI Inc. (TEM) offers a highly visible near-term growth runway in Diagnostics, offset by mid-term contract renewal uncertainty in the Data and Applications segment. The report is dated 21 September 2026.
Continue Reading
This article is for pass holders.
30-Day Pass$12.00One-time purchase · no auto-renewalBuy 30 DaysSave $24.00
365-Day Pass$120.00
Already a pass holder? Sign in · Continue with Google